MD · MBA
Founder & CEO, Sequencing.com
Founder of Sequencing and author of Outsmart Your Genes. An early voice in direct-to-consumer genetic testing.
Brandon Colby is a physician-expert in the fields of Genetic Analysis and Personalized Preventive Medicine. He holds an MD from the Mount Sinai School of Medicine, an MBA from Stanford University`s Graduate School of Business, and a BA with Honors in Genetics from the University of Michigan.
Dr. Colby is the author of the book Outsmart Your Genes and has developed numerous technologies that improve the analysis, interpretation, and actionability of genome sequencing data. He is an Affiliate Specialist of the American College of Medical Genetics and Genomics (ACMG), an Associate of the American College of Preventive Medicine (ACPM), and a member of the National Society of Genetic Counselors (NSGC).
Articles by Dr. Brandon Colby, MD are reviewed for accuracy by Sequencing's medical and scientific team. This page is for informational purposes and does not constitute medical advice.
Uncover how genetic testing aids in diagnosing and managing McCune-Albright Syndrome, offering insights into symptoms, treatment, and personalized care strategies.
Explore the crucial role of genetic testing in diagnosing and managing McLeod neuroacanthocytosis syndrome, ensuring accurate diagnosis, early intervention, and personalized care.
Genetic testing aids in diagnosing Meckel-Gruber Syndrome, revealing genetic mutations, informing family planning, and guiding research for potential therapies.
Explore Methylcrotonyl-CoA Carboxylase Deficiency and how genetic testing aids in early diagnosis, treatment, and family planning for this rare metabolic disorder.
Explore Microcephalic Osteodysplastic Dysplasia Saul-Wilson type, its diagnosis through genetic testing, family planning implications, and personalized treatment options.
Explore the impact of genetic testing in diagnosing and managing Morquio Syndrome. Learn about personalized treatments and family planning advancements today.
Explore how genetic testing, including whole genome sequencing, transforms Mucopolysaccharidosis (MPS) diagnosis, treatment, and family planning strategies.
Explore how genetic testing transforms multiminicore myopathy diagnosis, revealing genetic mutations, enabling early interventions, and guiding personalized treatments.